Drugmakers File 2nd Suit To Thwart Generic Xyzal

Law360, New York (May 29, 2008, 12:00 AM EDT) -- Belgian drugmaker UCB SA and its U.S. partner, Sepracor Inc., have filed their second lawsuit in two months in an effort to stave off a generic challenge to their antihistamine drug Xyzal.

The latest suit, filed Wednesday in the U.S. District Court for the Eastern District of North Carolina, alleges that Sun Pharmaceutical Industries Ltd. infringed the company's patent for levocetirizine dihydrochloride 5 mg tablets by filing an abbreviated new drug application with the U.S. Food and Drug Administration to make and sell generic Xyzal....
To view the full article, register now.